Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin) and 100 mg Clotrimazole (Canesten) for the Treatment of Vulvovaginal Candidiasis

Trial Profile

Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin) and 100 mg Clotrimazole (Canesten) for the Treatment of Vulvovaginal Candidiasis

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Dequalinium (Primary) ; Clotrimazole
  • Indications Vulvovaginal candidiasis
  • Focus Therapeutic Use
  • Sponsors Medinova
  • Most Recent Events

    • 14 Sep 2016 Status changed from recruiting to completed.
    • 06 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 26 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top